The topical formulation of whey protein for the prevention of pressure ulcers in critically ill patients: A novel intervention in a randomized-controlled clinical trial

Background: High prevalence of pressure ulcers (PUs) and their complications are important dilemmas in the intensive care unit (ICU). Therefore this study was designed to evaluate the effectiveness of topical whey protein formulation in preventing PUs in patients admitted to the ICU. Materials and M...

Full description

Bibliographic Details
Main Authors: Soroush Samimi, Saeed Abbasi, Azadeh Taheri, Shadi Farsaei
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Advanced Biomedical Research
Subjects:
Online Access:http://www.advbiores.net/article.asp?issn=2277-9175;year=2023;volume=12;issue=1;spage=168;epage=168;aulast=Samimi
_version_ 1797649509796282368
author Soroush Samimi
Saeed Abbasi
Azadeh Taheri
Shadi Farsaei
author_facet Soroush Samimi
Saeed Abbasi
Azadeh Taheri
Shadi Farsaei
author_sort Soroush Samimi
collection DOAJ
description Background: High prevalence of pressure ulcers (PUs) and their complications are important dilemmas in the intensive care unit (ICU). Therefore this study was designed to evaluate the effectiveness of topical whey protein formulation in preventing PUs in patients admitted to the ICU. Materials and Methods: In this randomized placebo-controlled clinical trial under registration number [IRCTdeted for blinded article], 80 eligible ICU patients were randomly allocated to receive topical ointment of whey protein or placebo on the sacrum with a diameter of 15 cm twice daily for seven days, in addition to the routine care. The mean risk score for developing PUs was calculated at baseline using the Braden tool, and the PUSH score was used to assess PUs on days 4, 7, and 14. Patients' related demographic and clinical variables were also collected using a medical record for more evaluation. Results: Our results showed that demographic characteristics and the Braden scores' baseline mean were not significantly different between groups (P > 0.05). The repeated measures ANOVA test revealed that the mean scores of PUs at various times were markedly lower in the whey protein than in the placebo group (P < 0.001). Conclusion: This intervention can be routinely added as effective, safe, inexpensive, and accessible care to reduce the incidence of PUs for patients at risk of developing this injury.
first_indexed 2024-03-11T15:48:08Z
format Article
id doaj.art-86e283561d0c44ab871cf0f57c5ceeb7
institution Directory Open Access Journal
issn 2277-9175
language English
last_indexed 2024-03-11T15:48:08Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Advanced Biomedical Research
spelling doaj.art-86e283561d0c44ab871cf0f57c5ceeb72023-10-26T05:43:17ZengWolters Kluwer Medknow PublicationsAdvanced Biomedical Research2277-91752023-01-0112116816810.4103/abr.abr_302_22The topical formulation of whey protein for the prevention of pressure ulcers in critically ill patients: A novel intervention in a randomized-controlled clinical trialSoroush SamimiSaeed AbbasiAzadeh TaheriShadi FarsaeiBackground: High prevalence of pressure ulcers (PUs) and their complications are important dilemmas in the intensive care unit (ICU). Therefore this study was designed to evaluate the effectiveness of topical whey protein formulation in preventing PUs in patients admitted to the ICU. Materials and Methods: In this randomized placebo-controlled clinical trial under registration number [IRCTdeted for blinded article], 80 eligible ICU patients were randomly allocated to receive topical ointment of whey protein or placebo on the sacrum with a diameter of 15 cm twice daily for seven days, in addition to the routine care. The mean risk score for developing PUs was calculated at baseline using the Braden tool, and the PUSH score was used to assess PUs on days 4, 7, and 14. Patients' related demographic and clinical variables were also collected using a medical record for more evaluation. Results: Our results showed that demographic characteristics and the Braden scores' baseline mean were not significantly different between groups (P > 0.05). The repeated measures ANOVA test revealed that the mean scores of PUs at various times were markedly lower in the whey protein than in the placebo group (P < 0.001). Conclusion: This intervention can be routinely added as effective, safe, inexpensive, and accessible care to reduce the incidence of PUs for patients at risk of developing this injury.http://www.advbiores.net/article.asp?issn=2277-9175;year=2023;volume=12;issue=1;spage=168;epage=168;aulast=Samimiintensive care unitpressure ulcerwhey protein
spellingShingle Soroush Samimi
Saeed Abbasi
Azadeh Taheri
Shadi Farsaei
The topical formulation of whey protein for the prevention of pressure ulcers in critically ill patients: A novel intervention in a randomized-controlled clinical trial
Advanced Biomedical Research
intensive care unit
pressure ulcer
whey protein
title The topical formulation of whey protein for the prevention of pressure ulcers in critically ill patients: A novel intervention in a randomized-controlled clinical trial
title_full The topical formulation of whey protein for the prevention of pressure ulcers in critically ill patients: A novel intervention in a randomized-controlled clinical trial
title_fullStr The topical formulation of whey protein for the prevention of pressure ulcers in critically ill patients: A novel intervention in a randomized-controlled clinical trial
title_full_unstemmed The topical formulation of whey protein for the prevention of pressure ulcers in critically ill patients: A novel intervention in a randomized-controlled clinical trial
title_short The topical formulation of whey protein for the prevention of pressure ulcers in critically ill patients: A novel intervention in a randomized-controlled clinical trial
title_sort topical formulation of whey protein for the prevention of pressure ulcers in critically ill patients a novel intervention in a randomized controlled clinical trial
topic intensive care unit
pressure ulcer
whey protein
url http://www.advbiores.net/article.asp?issn=2277-9175;year=2023;volume=12;issue=1;spage=168;epage=168;aulast=Samimi
work_keys_str_mv AT soroushsamimi thetopicalformulationofwheyproteinforthepreventionofpressureulcersincriticallyillpatientsanovelinterventioninarandomizedcontrolledclinicaltrial
AT saeedabbasi thetopicalformulationofwheyproteinforthepreventionofpressureulcersincriticallyillpatientsanovelinterventioninarandomizedcontrolledclinicaltrial
AT azadehtaheri thetopicalformulationofwheyproteinforthepreventionofpressureulcersincriticallyillpatientsanovelinterventioninarandomizedcontrolledclinicaltrial
AT shadifarsaei thetopicalformulationofwheyproteinforthepreventionofpressureulcersincriticallyillpatientsanovelinterventioninarandomizedcontrolledclinicaltrial
AT soroushsamimi topicalformulationofwheyproteinforthepreventionofpressureulcersincriticallyillpatientsanovelinterventioninarandomizedcontrolledclinicaltrial
AT saeedabbasi topicalformulationofwheyproteinforthepreventionofpressureulcersincriticallyillpatientsanovelinterventioninarandomizedcontrolledclinicaltrial
AT azadehtaheri topicalformulationofwheyproteinforthepreventionofpressureulcersincriticallyillpatientsanovelinterventioninarandomizedcontrolledclinicaltrial
AT shadifarsaei topicalformulationofwheyproteinforthepreventionofpressureulcersincriticallyillpatientsanovelinterventioninarandomizedcontrolledclinicaltrial